{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:20:34Z","timestamp":1791951634055,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpc.2025.101049","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:18:49Z","timestamp":1750277929000},"page":"101049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States"],"prefix":"10.1016","volume":"23","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4202-3928","authenticated-orcid":false,"given":"Dongying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.101049_bib0001","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101049_bib0002","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101049_bib0003","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.ajpc.2025.101049_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118585","article-title":"Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality","volume":"397","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101049_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2025.01.031","article-title":"Prevalence, disparities, and mortality of cardiovascular-kidney-metabolic syndrome in US adults, 2011-2018","author":"Kim","year":"2025","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2025.101049_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0007","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0009","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpc.2025.101049_bib0010","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"Bmj"},{"key":"10.1016\/j.ajpc.2025.101049_bib0011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0012","unstructured":"National Center for Health Statistics (NCHS). Analytic and reporting guidelines: the third national health and nutrition examination survey, NHANES III (1988-94). NHANES III Analytic and Reporting Guidelines; October 1996 (accessed November 16, 2024)."},{"key":"10.1016\/j.ajpc.2025.101049_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2025.101049_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13131","article-title":"National trends in American heart association revised life's simple 7 metrics associated with risk of mortality among US adults","volume":"2","author":"Han","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2025.101049_sbref0015","year":"1988"},{"key":"10.1016\/j.ajpc.2025.101049_bib0016","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpc.2025.101049_bib0017","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/apt.15580","article-title":"The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease","volume":"51","author":"Paik","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajpc.2025.101049_bib0018","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpc.2025.101049_bib0019","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101049_bib0021","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101049_bib0022","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/HYPERTENSIONAHA.123.21482","article-title":"Prevalence of chronic kidney disease among US adults with hypertension, 1999 to 2018","volume":"80","author":"Zeng","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2025.101049_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103588","article-title":"Role of oxidative balance score in staging and mortality risk of cardiovascular-kidney-metabolic syndrome: insights from traditional and machine learning approaches","volume":"81","author":"Chen","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000541889","article-title":"The interplay of nonalcoholic fatty liver disease and chronic kidney disease: a call for integrated management","author":"Zoccali","year":"2024","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0026","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12072-022-10304-z","article-title":"Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank","volume":"16","author":"Chahal","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ajpc.2025.101049_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - A systematic review and meta-analysis","volume":"21","author":"Tang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0028","article-title":"PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population","volume":"30","author":"Lu","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0029","first-page":"15","article-title":"From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajpc.2025.101049_bib0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.ajpc.2025.101049_bib0031","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0032","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0033","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpc.2025.101049_bib0034","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpc.2025.101049_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-025-01115-2","article-title":"\u039cetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment","author":"Byrne","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0036","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpc.2025.101049_bib0037","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101049_bib0038","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","article-title":"Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients","volume":"35","author":"Bril","year":"2015","journal-title":"Liver Int"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:56:40Z","timestamp":1760648200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"alternative-id":["S2666667725001242"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101049","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101049"}}